MobiHealth News December 7, 2022
Emily Olsen

The company said it will use the capital to hire for its commercial teams and advance development on new features.

Lokavant, which provides a data analytics platform for clinical trials, raised $21 million in a funding round led by Edison Partners.

Roivant Sciences, which builds health tech and biotech companies called “Vants,” participated in the raise. Lokavant was incubated at Roivant and piloted its platform with some of the company’s other biotech ventures. 

As part of the fundraise, Gregg Michaelson, general partner at Edison, will join Lokavant’s board of directors. 

WHAT THEY DO

Lokavant offers a centralized data repository for managing clinical trials. The platform allows users to input different data types and sources and view visualizations. 

They can also...

Today's Sponsors

Transcarent
SalesSparx

Today's Sponsor

Health Edge

 
Topics: Clinical Trials, Investments, Trends
Three Wild Health Technologies in (or Close to) Clinical Trials
How the Cloud Can Improve Data Sets for Real-World Evidence in Clinical Trials
Health Equity Barriers in Oncology Trials
Nationwide Children's Hospital AI spinoff acquired by new $200M clinical trial startup
Clinical trial company Science 37 buys life science assets from Vault Health

Share This Article